Eyepoint Pharmaceuticals Inc (EYPT)
5.67 -0.04 (-0.70%) 16:05 ET [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 5.67 unch (unch) 16:02 ET
for Tue, Apr 15th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -130,870 | -70,795 | -102,254 | -58,417 | -45,394 |
Depreciation Amortization | -4,413 | -392 | 22,587 | 3,399 | 3,394 |
Income taxes - deferred | 90 | 83 | N/A | N/A | N/A |
Accounts receivable | -244 | 14,432 | -2,662 | -10,603 | 4,846 |
Accounts payable and accrued liabilities | 5,731 | 1,519 | 1,198 | 8,476 | 1,872 |
Other Working Capital | -27,773 | 58,882 | -3,023 | -1,739 | 20,136 |
Other Operating Activity | 31,253 | -1,854 | 19,149 | 8,787 | 711 |
Operating Cash Flow | $-126,226 | $1,875 | $-65,005 | $-50,097 | $-14,435 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 183,000 | 55,284 | N/A | N/A | N/A |
PPE Investments | -4,052 | -3,483 | -2,150 | -156 | -362 |
Purchase Of Investment | -398,303 | -55,116 | -139,115 | -32,965 | 0 |
Sale Of Investment | N/A | N/A | 124,000 | N/A | N/A |
Investing Cash Flow | $-219,355 | $-3,315 | $-17,265 | $-33,121 | $-362 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 5,300 | 73,875 | N/A | 2,041 |
Debt Repayment | -105 | -45,811 | -71,772 | -146 | -13,843 |
Common Stock Issued | 169,311 | 229,551 | 395 | 217,198 | 50,212 |
Other Financing Activity | -5,184 | -1,970 | -3,188 | -150 | -918 |
Financing Cash Flow | $164,022 | $187,070 | $-690 | $216,902 | $37,492 |
Beginning Cash Position | 281,413 | 95,783 | 178,743 | 45,059 | 22,364 |
End Cash Position | 99,854 | 281,413 | 95,783 | 178,743 | 45,059 |
Net Cash Flow | $-181,559 | $185,630 | $-82,960 | $133,684 | $22,695 |
Free Cash Flow | |||||
Operating Cash Flow | -126,226 | 1,875 | -65,005 | -50,097 | -14,435 |
Capital Expenditure | -4,052 | -3,483 | -2,150 | -156 | -362 |
Free Cash Flow | -130,278 | -1,608 | -67,155 | -50,253 | -14,797 |